18.12.2023 • News

Samyang Holdings Acquires Verdant Specialty Solutions

Samyang Holdings has acquired the management rights of the U.S.-based specialty chemical manufacturer Verdant Specialty Solutions from private equity firm OpenGate Capital. The total acquisition was approximately €230 million ($250 million).

This move aligns with Samyang Group’s push to strengthen its specialty business interests and accelerate its global operations as the group aims to achieve an annual revenue of  €4.2 billion (₩6 trillion) by 2025.


Headquartered in Texas, Verdant supplies amphoteric and non-ionic surfactants for personal care and industrial applications with an annual revenue of around €190 million ($210 million).


Verdant has a diverse client base that includes global personal care brands like Unilever and L'Oréal and industrial chemical manufacturers, It has production bases in the U.S., U.K., and Germany and has positioned itself with steady growth potential in developed markets.


Samyang Holdings is the holding company of Samyang Group, which operates chemical, food, biopharmaceutical, and packaging businesses. Having entered the personal care specialty business by acquiring the Korean-listed company KCI in 2017, Samyang Group is anticipating synergy and strengthened competitiveness between Verdant and KCI based on their complementary product portfolios.

Kim Yoon, chairman of Samyang Holdings, commented, "The acquisition of Verdant is the start of our plan to pursue M&As and joint ventures with various suitable global partners in addition to our internal capabilities. We’re inheriting Verdant’s excellence - including people, technology, and products - as we actively support Samyang Group’s goal of developing as a global leader.”

“We are excited to become a part of a dynamic and forward-looking company with such a complimentary portfolio of technologies while extending Verdant’s reach. The acquisition of Verdant by Samyang Holdings, a strategic buyer, is a great evolution for Verdant and its employees,” stated Todd Nelmark the New CEO of Verdant Specialty Solutions.

Samyang Holdings and OpenGate Capital hold a Verdant MIPA signing ceremony in...
Samyang Holdings and OpenGate Capital hold a Verdant MIPA signing ceremony in Texas on December 15. (From left to right) Eom Tae-ung, President of Samyang Holdings, and Matthias Gundlach, Managing Director of OpenGate Capital. © Samyang Holdings

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.